Substance
ERLIZUMAB
Global reference: every product and company linked to this substance.
- cas: 211323-03-4
- ncit: C169959
- unii: X77RS4CMJF
erlizumab [INN] · ERLIZUMAB [USAN] · Erlizumab [WHO-DD] · RHUMAB CD18 · RHUMAB-CD18
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.